Last reviewed · How we verify

NCT07239024

Evaluation of Piezocision Versus Injectable Platelet-rich Fibrin During Orthodontic Canine Retraction Orthodontic Canine Retraction: A Comparative Clinical Study

ENROLLING BY INVITATION Phase 1 Last updated 20 November 2025
What this trial tests

Phase 1 trial testing Iprf and piezocision in Effect of Piezocision and Injectable Platelets Rich Fibrin on Tooth Movement in 16 participants. Enrolling by invitation.

Timeline
1 December 2025
Primary endpoint
1 April 2026
20 April 2026

Quick facts

Lead sponsorAl-Azhar University
PhasePhase 1
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingnone
Primary purposebasic science
Enrollment16
Start date1 December 2025
Primary completion1 April 2026
Estimated completion20 April 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 14 to 22, any sex, with Effect of Piezocision and Injectable Platelets Rich Fibrin on Tooth Movement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of piezocisin and injectable platelets rich fibrin during canine retraction

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07239024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing